Tiemann Investment Advisors LLC lowered its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 2.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 855 shares of the semiconductor company’s stock after selling 25 shares during the quarter. Tiemann Investment Advisors LLC’s holdings in Synopsys were worth $367,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently bought and sold shares of SNPS. Brighton Jones LLC raised its holdings in shares of Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after buying an additional 50 shares during the last quarter. XTX Topco Ltd purchased a new position in shares of Synopsys in the 4th quarter valued at approximately $228,000. Jump Financial LLC acquired a new stake in shares of Synopsys during the fourth quarter worth $453,000. NewEdge Advisors LLC grew its position in Synopsys by 5.1% in the 4th quarter. NewEdge Advisors LLC now owns 2,615 shares of the semiconductor company’s stock valued at $1,269,000 after buying an additional 127 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC raised its position in Synopsys by 516.0% during the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 154 shares of the semiconductor company’s stock worth $75,000 after buying an additional 129 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Insider Buying and Selling at Synopsys
In other news, CFO Shelagh Glaser sold 7,310 shares of the firm’s stock in a transaction on Friday, June 6th. The stock was sold at an average price of $485.72, for a total transaction of $3,550,613.20. Following the sale, the chief financial officer owned 15,291 shares in the company, valued at $7,427,144.52. This trade represents a 32.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CRO Richard S. Mahoney sold 9,010 shares of the firm’s stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total value of $4,245,602.10. Following the completion of the sale, the executive directly owned 1,485 shares in the company, valued at approximately $699,746.85. The trade was a 85.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 27,686 shares of company stock worth $13,001,048. Insiders own 0.62% of the company’s stock.
Synopsys Stock Down 1.9%
Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.40 by $0.27. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.60 billion. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the firm earned $3.00 EPS. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. As a group, equities research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on the company. Morgan Stanley reaffirmed an “overweight” rating and issued a $715.00 price objective (up previously from $540.00) on shares of Synopsys in a report on Monday, August 11th. Needham & Company LLC reissued a “buy” rating and set a $660.00 price objective (up previously from $650.00) on shares of Synopsys in a report on Tuesday, July 15th. Piper Sandler increased their target price on shares of Synopsys from $615.00 to $660.00 and gave the company an “overweight” rating in a report on Monday, July 21st. The Goldman Sachs Group started coverage on Synopsys in a research note on Thursday, July 10th. They set a “buy” rating and a $620.00 price target on the stock. Finally, Bank of America lifted their price objective on Synopsys from $575.00 to $625.00 and gave the stock a “buy” rating in a report on Wednesday, July 16th. Thirteen analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $630.67.
Read Our Latest Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- How to Invest in the Best Canadian Stocks
- Toll Brothers: A Great Buy and Hold Stock With Risks in 2025
- Overbought Stocks Explained: Should You Trade Them?
- Lowe’s Builds Value for Investors: Still a Good Buy in 2025
- Investing in the High PE Growth Stocks
- Jackson Hole 2025: Fed’s Signal Could Shift Stocks Fast
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.